Intra-lesional immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Intra-lesional immunotherapy, covering 2025-12-31 to 2025-12-31. Get the full timeline:
Most recent: Clinical Trial Update: A Pilot Study to Evaluate the Therapeutic Efficacy of Intra-Lesional Immunotherapy in Patients Aged 10-60 Years With Recalcitrant Tinea Cruris and Corporis [NA]